Sep 3, 2014 | Research News
Medscape Medical News Lisa Nainggolan August 11, 2014 The novel inhaled insulin product, Afrezza, recently approved for use in the United States, will be launched there at the beginning of next year following a commercial agreement signed between the manufacturer,...
Sep 3, 2014 | Featured, Technology Updates
Howard Look, CEO of Tidepool, front, second from leftWe recently had an opportunity to interview Howard Look, CEO of Tidepool, an innovative, open source approach to managing data from diabetes devices. Both Howard Look and Tidepool’s co-founder and CTO, Steve...